Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALDX |
---|---|---|
09:32 ET | 5083 | 5.45 |
09:34 ET | 17394 | 5.49 |
09:36 ET | 1576 | 5.455 |
09:38 ET | 11391 | 5.365 |
09:39 ET | 20397 | 5.435 |
09:41 ET | 1606 | 5.47 |
09:43 ET | 3000 | 5.485 |
09:45 ET | 8108 | 5.54 |
09:48 ET | 3800 | 5.51 |
09:50 ET | 10246 | 5.54 |
09:52 ET | 1600 | 5.52 |
09:54 ET | 1454 | 5.545 |
09:56 ET | 1000 | 5.57 |
09:57 ET | 3520 | 5.54 |
09:59 ET | 4500 | 5.59 |
10:01 ET | 1159 | 5.6 |
10:03 ET | 700 | 5.6 |
10:06 ET | 1440 | 5.6 |
10:08 ET | 4489 | 5.58 |
10:10 ET | 657 | 5.569 |
10:12 ET | 1206 | 5.575 |
10:14 ET | 31855 | 5.56 |
10:15 ET | 1415 | 5.59 |
10:17 ET | 1926 | 5.55 |
10:21 ET | 3088 | 5.53 |
10:24 ET | 389 | 5.525 |
10:26 ET | 5860 | 5.5416 |
10:28 ET | 955 | 5.54 |
10:30 ET | 500 | 5.5319 |
10:32 ET | 426 | 5.57 |
10:33 ET | 300 | 5.58 |
10:35 ET | 200 | 5.59 |
10:37 ET | 731 | 5.595 |
10:39 ET | 428 | 5.59 |
10:42 ET | 100 | 5.58 |
10:44 ET | 100 | 5.6 |
10:46 ET | 900 | 5.56 |
10:48 ET | 100 | 5.57 |
10:50 ET | 835 | 5.53 |
10:53 ET | 486 | 5.52 |
10:55 ET | 1200 | 5.495 |
10:57 ET | 15925 | 5.4905 |
11:00 ET | 300 | 5.52 |
11:02 ET | 1840 | 5.46 |
11:06 ET | 100 | 5.48 |
11:08 ET | 1857 | 5.495 |
11:09 ET | 2990 | 5.49 |
11:11 ET | 1014 | 5.48 |
11:13 ET | 622 | 5.49 |
11:15 ET | 200 | 5.51 |
11:18 ET | 2863 | 5.48 |
11:20 ET | 100 | 5.49 |
11:22 ET | 500 | 5.51 |
11:24 ET | 500 | 5.49 |
11:26 ET | 100 | 5.51 |
11:27 ET | 500 | 5.48 |
11:29 ET | 100 | 5.49 |
11:31 ET | 300 | 5.47 |
11:33 ET | 2565 | 5.49 |
11:36 ET | 200 | 5.49 |
11:38 ET | 300 | 5.49 |
11:40 ET | 1644 | 5.47 |
11:42 ET | 3548 | 5.46 |
11:45 ET | 300 | 5.46 |
11:47 ET | 300 | 5.45 |
11:49 ET | 1200 | 5.43 |
11:54 ET | 408 | 5.43 |
11:56 ET | 696 | 5.43 |
11:58 ET | 100 | 5.43 |
12:02 ET | 600 | 5.425 |
12:03 ET | 1177 | 5.41 |
12:05 ET | 2000 | 5.39 |
12:07 ET | 1127 | 5.39 |
12:12 ET | 919 | 5.4 |
12:14 ET | 526 | 5.39 |
12:16 ET | 400 | 5.4 |
12:18 ET | 400 | 5.4 |
12:20 ET | 1400 | 5.41 |
12:21 ET | 100 | 5.42 |
12:23 ET | 300 | 5.42 |
12:25 ET | 500 | 5.43 |
12:27 ET | 1600 | 5.43 |
12:30 ET | 200 | 5.44 |
12:32 ET | 300 | 5.43 |
12:34 ET | 200 | 5.44 |
12:36 ET | 400 | 5.44 |
12:38 ET | 500 | 5.44 |
12:39 ET | 1800 | 5.44 |
12:41 ET | 800 | 5.43 |
12:43 ET | 632 | 5.44 |
12:45 ET | 2628 | 5.3952 |
12:48 ET | 100 | 5.42 |
12:50 ET | 100 | 5.41 |
12:52 ET | 1000 | 5.408 |
12:54 ET | 100 | 5.41 |
12:56 ET | 200 | 5.42 |
12:57 ET | 1700 | 5.41 |
01:01 ET | 1858 | 5.38 |
01:03 ET | 3419 | 5.35 |
01:08 ET | 874 | 5.37 |
01:10 ET | 218 | 5.37 |
01:12 ET | 11171 | 5.42 |
01:14 ET | 803 | 5.41 |
01:15 ET | 200 | 5.41 |
01:17 ET | 102 | 5.3966 |
01:19 ET | 1050 | 5.41 |
01:21 ET | 200 | 5.41 |
01:24 ET | 600 | 5.41 |
01:26 ET | 4712 | 5.38 |
01:28 ET | 200 | 5.38 |
01:32 ET | 7693 | 5.33 |
01:33 ET | 200 | 5.33 |
01:37 ET | 1414 | 5.32 |
01:39 ET | 1913 | 5.32 |
01:42 ET | 600 | 5.32 |
01:44 ET | 4063 | 5.3 |
01:46 ET | 11941 | 5.31 |
01:48 ET | 326 | 5.32 |
01:50 ET | 400 | 5.32 |
01:51 ET | 300 | 5.32 |
01:53 ET | 318 | 5.3299 |
01:55 ET | 889 | 5.33 |
01:57 ET | 1821 | 5.34 |
02:00 ET | 1714 | 5.33 |
02:04 ET | 100 | 5.33 |
02:06 ET | 200 | 5.34 |
02:08 ET | 1300 | 5.32 |
02:09 ET | 126 | 5.31 |
02:11 ET | 200 | 5.31 |
02:13 ET | 1767 | 5.29 |
02:15 ET | 7646 | 5.27 |
02:18 ET | 1700 | 5.26 |
02:20 ET | 917 | 5.28 |
02:22 ET | 1704 | 5.27 |
02:24 ET | 7363 | 5.29 |
02:26 ET | 1259 | 5.3 |
02:27 ET | 3140 | 5.32 |
02:29 ET | 361 | 5.33 |
02:31 ET | 300 | 5.34 |
02:33 ET | 1050 | 5.34 |
02:36 ET | 100 | 5.34 |
02:38 ET | 1967 | 5.35 |
02:40 ET | 100 | 5.34 |
02:42 ET | 689 | 5.35 |
02:44 ET | 200 | 5.35 |
02:45 ET | 300 | 5.36 |
02:47 ET | 300 | 5.36 |
02:49 ET | 1127 | 5.37 |
02:51 ET | 1785 | 5.3542 |
02:54 ET | 100 | 5.36 |
02:56 ET | 100 | 5.36 |
02:58 ET | 700 | 5.34 |
03:00 ET | 600 | 5.33 |
03:02 ET | 1079 | 5.32 |
03:03 ET | 840 | 5.3201 |
03:09 ET | 5888 | 5.31 |
03:12 ET | 400 | 5.33 |
03:14 ET | 1230 | 5.3 |
03:16 ET | 500 | 5.32 |
03:18 ET | 300 | 5.32 |
03:20 ET | 1194 | 5.32 |
03:21 ET | 500 | 5.33 |
03:23 ET | 200 | 5.34 |
03:25 ET | 4928 | 5.35 |
03:27 ET | 601 | 5.37 |
03:30 ET | 2800 | 5.38 |
03:32 ET | 600 | 5.38 |
03:34 ET | 1631 | 5.37 |
03:36 ET | 1617 | 5.36 |
03:38 ET | 100 | 5.37 |
03:39 ET | 700 | 5.365 |
03:41 ET | 1400 | 5.37 |
03:43 ET | 1674 | 5.36 |
03:45 ET | 1950 | 5.365 |
03:48 ET | 2207 | 5.36 |
03:50 ET | 4203 | 5.35 |
03:52 ET | 4985 | 5.38 |
03:54 ET | 6727 | 5.37 |
03:56 ET | 8887 | 5.379 |
03:57 ET | 4782 | 5.375 |
03:59 ET | 708957 | 5.39 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Aldeyra Therapeutics Inc | 320.3M | -8.4x | --- |
Nkarta Inc | 318.9M | -2.2x | --- |
Monte Rosa Therapeutics Inc | 325.3M | -2.4x | --- |
Inozyme Pharma Inc | 328.1M | -3.6x | --- |
Korro Bio Inc | 310.8M | -1.1x | --- |
Corvus Pharmaceuticals Inc | 330.3M | -11.8x | --- |
Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in discovering therapies designed to treat immune-mediated diseases. The Company's product candidates include reactive aldehyde species (RASP) modulators ADX-629, ADX-246, ADX-248, and chemically related molecules for the treatment of systemic and retinal immune-mediated diseases. Its pre-commercial product candidates are reproxalap, a RASP modulator for the potential treatment of dry eye disease and allergic conjunctivitis, and ADX-2191, a novel formulation of intravitreal methotrexate for the treatment of proliferative vitreoretinopathy and retinitis pigmentosa. Its ADX-629, is an orally administered RASP modulator in clinical development for atopic dermatitis, idiopathic nephrotic syndrome, moderate alcohol-associated hepatitis, chronic cough, and Sjogren-Larsson Syndrome. Its preclinical RASP platform includes ADX-246 and ADX-248 in development for metabolic, retinal diseases and systemic inflammatory diseases.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $320.3M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 59.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.43 |
EPS | $-0.64 |
Book Value | $2.02 |
P/E Ratio | -8.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.